Gilead Sciences, Inc. (GILD) results explained: sales up 7%

Quantooo Lab · 2026-10-29

What happened?

Gilead Sciences, Inc. (GILD) reported results on 29 Oct, covering the 9 months to 30 Sep.

The numbers in plain words

Sales were up 7.2% compared with the same period a year earlier. Costs were larger than sales, a loss of about 19 for every 100 of sales running costs (operating margin -18.8%), lower than a year earlier (37.4%). The company is funded more by borrowing than a year ago (75% of assets vs 63%).

Source: the company's 10-Q filed 2026-10-30.

How did the share price react?

Since the results, the share price has moved +6.99% (to the close of 2 Nov), while the S&P 500 moved −2.62%.

What changed in our score?

Our score went from 58 to 56 out of 100; the fundamentals part went from 16 to 16. Every step of the calculation: GILD stock page.

How bumpy could the next month be?

Our volatility model expects the next month to be bumpier than usual for GILD (26% a year vs a normal 25%).

What does it mean?

Results describe the past few months. They don't tell you where the price goes next, and our own tests found our scores don't reliably predict that either.

Educational, not investment advice.